Details for Patent: 10,953,000
✉ Email this page to a colleague
Which drugs does patent 10,953,000 protect, and when does it expire?
Patent 10,953,000 protects NUPLAZID and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 10,953,000
| Title: | Combination of pimavanserin and cytochrome P450 modulators |
| Abstract: | A method for treating a disease or disorder in a patient who is currently taking a cytochrome P450 inhibitor comprising administering to the patient a dose of pimavanserin or a pharmaceutical acceptable salt thereof, wherein the dose is at least 20% lower than a dose of pimavanserin or a pharmaceutical acceptable salt thereof that would otherwise have been recommended to the patient if the patient were not currently taking the cytochrome P450 inhibitor. |
| Inventor(s): | Parkinson; Andrew (Shawnee, KS) |
| Assignee: | ACADIA Pharmaceuticals Inc. (San Diego, CA) |
| Application Number: | 16/087,604 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,953,000
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate | TABLET;ORAL | 207318-002 | Jun 28, 2018 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF HALLUCINATIONS AND DELUSIONS ASSOCIATED WITH PARKINSON'S DISEASE PSYCHOSIS | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,953,000
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 1630068-3 | Apr 4, 2016 |
| PCT Information | |||
| PCT Filed | March 23, 2017 | PCT Application Number: | PCT/US2017/023795 |
| PCT Publication Date: | September 28, 2017 | PCT Publication Number: | WO2017/165635 |
International Family Members for US Patent 10,953,000
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2017165635 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
